| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/28/2013 | US20130052165 Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby |
| 02/28/2013 | CA2846015A1 Conditionally replicating adenovirus |
| 02/27/2013 | EP2561081A1 Reverse genetics of negative-strand rna viruses in yeast |
| 02/27/2013 | EP2561067A2 Raav-guanylate cyclase compositions and methods for treating leber's congenital amaurosis-1 (lca1) |
| 02/27/2013 | EP2561065A2 Cell culture medium comprising small peptides |
| 02/27/2013 | CN102947453A A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy |
| 02/27/2013 | CN102268410B Newcastle disease virus heat-resistant attenuated strain adapted to baby hamster kidney passage cell and preparation method and application thereof |
| 02/27/2013 | CN102250843B Genetic engineering marked attenuated vaccine strain of porcine reproductive and respiratory syndrome virus and application thereof |
| 02/27/2013 | CN102154219B Swine influenza A H1N1 virus and use thereof |
| 02/27/2013 | CN101018860B Flavivirus vaccine |
| 02/26/2013 | US8383333 HBV precore protein capable of forming particles |
| 02/26/2013 | US8383131 Porcine reproductive and respiratory syndrome isolates and methods of use |
| 02/26/2013 | US8383129 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 02/26/2013 | CA2509979C Alphavirus particles and methods for preparation |
| 02/26/2013 | CA2509973C Multi-antigenic alphavirus replicon particles and methods |
| 02/26/2013 | CA2493406C Gm-negative ehv-mutants without heterologous elements |
| 02/26/2013 | CA2430115C Recombinant rsv virus expression systems and vaccines |
| 02/21/2013 | WO2013026054A2 Production of infectious rna viruses in yeast |
| 02/21/2013 | WO2013024304A1 Bacteriophages |
| 02/21/2013 | US20130045230 Composition containing hcmv particles |
| 02/21/2013 | US20130045186 Method of Detecting and/or Identifying Adeno-Associated Virus (AAV) Sequences and Isolating Novel Sequences Identified Thereby |
| 02/20/2013 | EP2558117A1 Expression of positive sense single stranded rna virus and uses thereof |
| 02/20/2013 | CN102936279A Plant somatic embryogenesis gap-associated protein GhSERK2 as well as encoding gene and application thereof |
| 02/19/2013 | US8377678 Methodology for detection, enumeration, propagation and manipulation of bacteriophages |
| 02/19/2013 | US8377672 Ligand functionalized polymers |
| 02/19/2013 | CA2467930C Treatment of pml targeting jc virus agno |
| 02/14/2013 | WO2013022717A1 Pure filamentous bacteriophage and methods of producing same |
| 02/14/2013 | WO2012169939A9 Recombinant dna elements for the expression of recombinant proteins in a host cell |
| 02/14/2013 | US20130041023 Composition for Preventing or Treating Rotavirus Infection Comprising Licorice Extract |
| 02/14/2013 | US20130040370 Novel Method for Vacuum-Assisted Preservation of Biologics Including Vaccines |
| 02/14/2013 | US20130040369 Gammaretrovirus Associated With Cancer |
| 02/14/2013 | US20130040284 Hbv drug resistance methods |
| 02/14/2013 | US20130039972 Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| 02/14/2013 | US20130039946 Vaccine comprising an attenuated pestivirus |
| 02/14/2013 | US20130039943 Novel method |
| 02/14/2013 | US20130039942 Compositions and Methods for Self-Adjuvanting Vaccines against Microbes and Tumors |
| 02/13/2013 | EP2556151A1 Method for generating a parvovirus b19 virus-like particle |
| 02/13/2013 | EP2556150A1 Viral particle released after infection of mammalian cells by human cytomegalovirus (hcmv) containing a fusion protein and use thereof |
| 02/13/2013 | CN102933706A Viral particle released after infection of mammalian cells by human cytomegalovirus (hcmv) containing a fusion protein and use thereof |
| 02/13/2013 | CN102925486A Porcine circovirus type 2 subunit vaccine, and preparation method and application thereof |
| 02/13/2013 | CN102925476A Preparation method and application of self-combined immunogenic enterovirus-like particles in yeast |
| 02/13/2013 | CN102925415A Silkworm recombination baculovirus expressing paraoxonase 1 gene and preparation method and application thereof |
| 02/13/2013 | CN102925414A Swine Japanese encephalitis virus strain and application thereof |
| 02/13/2013 | CN102924604A Recombined vessel endothelium growth factor receptor, encoding genes thereof and application |
| 02/13/2013 | CN102921020A Gene drug for combined treatment on tumors, and use thereof |
| 02/13/2013 | CN102352365B Method for clearing away mycoplasma from pseudorabies vaccine strains |
| 02/13/2013 | CN102344914B Construction and application of recombinant MDV (Marek's Disease Virus) strain for expressing REV env (Reticuloendotheliosis Viruses envelope) |
| 02/13/2013 | CN102159705B Mutant pestivirus with mutations in core gene and ns3 region |
| 02/13/2013 | CN101993498B Adenovirus vector avian influenza recombinant vaccine |
| 02/13/2013 | CN101942417B Separated bacteriophages of enterobacter sakazakii, combination and application thereof |
| 02/13/2013 | CN101238209B 登革血清型2减毒株 Save dengue serotype 2 strain |
| 02/13/2013 | CN101048498B Virosome particles comprising antigens from influenza virus and hepatitis b virus |
| 02/12/2013 | US8372622 Modified vaccinia virus ankara for the vaccination of neonates |
| 02/12/2013 | CA2442594C Vip3 pesticidal toxin from bacillus thuringiensis |
| 02/12/2013 | CA2365903C Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
| 02/12/2013 | CA2309114C Immortalized, homozygous stat1-deficient mammalian cell lines and their uses |
| 02/12/2013 | CA2304350C Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 02/12/2013 | CA2289277C Targeted gene modification by parvoviral vectors |
| 02/12/2013 | CA2274490C Non-m non-o hiv strains, fragments and applications |
| 02/07/2013 | WO2013019800A1 Vlps containing ligands and methods related thereto |
| 02/07/2013 | WO2013017570A1 Novel prrs virus inducing type i interferon in susceptible cells |
| 02/07/2013 | WO2013017568A1 INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF |
| 02/07/2013 | WO2013017272A1 Method for purifying virus-like particles (vlp) |
| 02/07/2013 | WO2013016805A1 Recombinant swine influenza virus and uses thereof |
| 02/07/2013 | WO2012145624A3 Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies |
| 02/07/2013 | US20130035381 Virus-inactivating composition containing low-molecular weight compound and arginine |
| 02/07/2013 | US20130034586 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response |
| 02/07/2013 | US20130034585 Bovine Herpes Virus Vaccine With Multiple Mutations |
| 02/07/2013 | US20130034584 Agent for use in the topical or local treatment of cervical dysplasias |
| 02/07/2013 | US20130034582 Reverse genetics methods for virus rescue |
| 02/07/2013 | US20130034581 Genetically engineered swine influenza virus and uses thereof |
| 02/07/2013 | CA2842872A1 Recombinant swine influenza virus and uses thereof |
| 02/06/2013 | EP2554664A1 Method for purifying virus-like particles |
| 02/06/2013 | EP2552465A1 Stabilisation of viral particles |
| 02/06/2013 | CN102911948A Method for detecting enterovirus neutralizing antibody and special recombinant virus for method |
| 02/06/2013 | CN102911947A Porcine circovirus (PCV) type 2 Cap protein and preparation method thereof |
| 02/06/2013 | CN102911920A KMB17 cell-adapted strain for II type dengue virus and preparation method thereof |
| 02/06/2013 | CN102911911A Monoclonal cell strain of human embryo kidney cell 293T-C10 as well as preparation and application of monoclonal cell strain |
| 02/06/2013 | CN102268456B Her-2/neu recombinant adeno-associated virus vector and construction method as well as application thereof |
| 02/06/2013 | CN101948815B EV-71(Enterovirus 71) type viral plaque purification method |
| 02/06/2013 | CN101348780B Method of isolation and purification of trypsin from pronase protease and use thereof |
| 02/05/2013 | US8367401 Replication competent hepatitis C virus and methods of use |
| 02/05/2013 | US8367391 Method for detecting or determining abnormal prion protein associated with transmissible spongiform encephalopathy in blood-derived specimen or body fluid-derived specimen |
| 02/05/2013 | US8367074 Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| 02/05/2013 | US8367068 Use of triplex structure DNA in transferring nucleotide sequences |
| 02/05/2013 | CA2320359C Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 02/05/2013 | CA2301199C A tumor suppressor designated ts10q23.3 |
| 01/31/2013 | WO2013016644A1 Process for the production of filamentous bacteriophage |
| 01/31/2013 | WO2013014537A1 Virus-based vector compositions useful for transducing eukaryotic cells |
| 01/31/2013 | WO2013014400A1 Baculovirus system for the expression of a gene therapy vector |
| 01/31/2013 | WO2013014256A1 Production of recombinant protein in insect cells using a baculovirus expression system |
| 01/31/2013 | US20130028931 Novel prrs virus inducing type i interferon in susceptible cells |
| 01/31/2013 | CA2843165A1 Virus-based vector compositions useful for transducing eukaryotic cells |
| 01/31/2013 | CA2843042A1 Baculovirus system for the expression of a gene therapy vector |
| 01/31/2013 | CA2842798A1 Recombinant virus products and methods for inhibition of expression of dux4 |
| 01/30/2013 | EP2551345A1 Hcv variant with high productivity of infectious hepatitis c virus, and use thereof |
| 01/30/2013 | EP2551285A1 Temperature-, ph- or salt concentration-sensitive separation material and use thereof |
| 01/30/2013 | EP2550362A2 Cmv glycoproteins and recombinant vectors |
| 01/30/2013 | EP2550292A2 Flavivirus host range mutations and uses thereof |
| 01/30/2013 | EP2549859A1 Primate model from the family cercopithecidae infected by a hbv strain of human genotype |